Innovative Neurostimulation Micro-Leads specializes in developing advanced injectable and laparoscopic devices for precision neurostimulation, positioning it as a leader in minimally invasive, surgery-free neurological treatments suitable for clinics seeking cutting-edge medical solutions.

Recent Regulatory Progress The company achieved FDA Investigational Device Exemption approval for its high-definition spinal cord stimulation system, opening opportunities to collaborate with healthcare providers involved in innovative neuromodulation therapies.

Strong Research Recognition Winning the Paper of the Year at the Congress of Neurological Surgeons underscores Micro-Leads' credibility and technical leadership, making it an attractive partner for research institutions and hospitals investing in advanced neurotech.

Funding and Innovation Supported by NIH funding through the HEAL award, Micro-Leads demonstrates its capacity for impactful innovation with potential for growth, appealing to medical device companies and investors looking to collaborate on cutting-edge neurological health solutions.

Growth Potential Despite Small Scale With a dedicated team of 2-10 employees and revenues between 1 and 10 million dollars, Micro-Leads offers accessible partnership opportunities for larger firms seeking innovative neurostimulation technology to expand their portfolio.